KASEY GORA: Open Payments
NPI 1922447028 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 38 payments from 12 companies in 2025. Trend: 2023 $846 · 2024 $990 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $137 |
| Ardelyx, Inc. | 6 | $112 |
| Celltrion USA Inc. | 4 | $102 |
| Janssen Biotech, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $49 |
| GENZYME CORPORATION | 2 | $41 |
| Madrigal Pharmaceuticals | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| Gilead Sciences, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: IBSRELA, VEGZELMA, TREMFYA, CREON, LINZESS, DUPIXENT, REZDIFFRA, IQIRVO.
Industry payments across LA — which companies pay providers there.
